← SynDRA
ANAMORELIN
SynDRA canonical compound SYN0033289 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | GHSR |
|---|
| Mechanism of action | Growth hormone secretagogue receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Growth hormone secretagogue receptor agonist
- GHSR AGONIST
- Ghrelin receptor agonist
- GHSR STIMULATOR
- Modulator
Cross-references
Synonyms
- anamorelin hydrochloride
- adlumiz
- ONO-7643
- ST-1291
- RC-1291
- Anamoreline
- Anamorelina
- UNII-DD5RBA1NKF
- DD5RBA1NKF
- Anamorelin [INN]
- SCHEMBL935751
- CHEMBL2110579
- EX-A154
- DTXSID20179702
- C31H42N6O3
- BCP06108
- 3444AH
- ZINC43130908
- AKOS030526752
- SB16911
- API0008642
- NCGC00378854-01
- KB-80338
- HY-14734
- BC600755
- (3R)-1-(2-Methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
- AB0165721
- FT-0773543
- W-5500
- 921A195
- CS 1036
- RC 1291
- anamorelina
- anamoreline
- anamorelinum
- RefChem:112510
- DTXCID40102193
- MFCD11973671
Look up ANAMORELIN in the interactive SynDRA portal →